Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Buspirone 5mg tablets
0401020B0AAAAAA
|
Buspirone hydrochloride | Buspirone hydrochloride | Central Nervous System | 29,868 |
|
Buspirone 10mg tablets
0401020B0AAABAB
|
Buspirone hydrochloride | Buspirone hydrochloride | Central Nervous System | 17,683 |
|
Buspirone 15mg tablets
0401020B0AAAEAE
|
Buspirone hydrochloride | Buspirone hydrochloride | Central Nervous System | 388 |
|
Buspirone 7.5mg tablets
0401020B0AAADAD
|
Buspirone hydrochloride | Buspirone hydrochloride | Central Nervous System | 49 |
|
Buspirone 5mg/5ml oral solution
0401020B0AAACAC
|
Buspirone hydrochloride | Buspirone hydrochloride | Central Nervous System | 42 |
|
Buspirone 30mg tablets
0401020B0AAAFAF
|
Buspirone hydrochloride | Buspirone hydrochloride | Central Nervous System | 17 |
|
Buspirone 5mg/5ml oral suspension
0401020B0AAAGAG
|
Buspirone hydrochloride | Buspirone hydrochloride | Central Nervous System | 3 |
|
Buspar 10mg tablets
0401020B0BBABAB
|
Buspar | Buspirone hydrochloride | Central Nervous System | No data available |
|
Buspar 5mg tablets
0401020B0BBAAAA
|
Buspar | Buspirone hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.